Criteria defining the systemic inflammatory response syndrome (SIRS) were used to assess prospectively 270 clinical episodes in which blood cultures were taken from patients in general medicine. SIRS, severe sepsis and septic shock occurred in 149 (55%), 13 (5%) and 9 (3%) episodes, respectively. However, evidence of organ hypoperfusion indicating severe sepsis was recorded as sought in only 26% of episodes of SIRS. Crude mortality at 28 days increased sequentially as more SIRS criteria were met, rising from 12% in nonSi RS blood culture episodes, to 36% when all four criteria were met. Mortality from severe sepsis and septic shock was 38% and 56%, respectively. In 61/64 (95%) episodes of clinically important bacteraemia, patients fulfilled SIRS criteria when the blood culture was taken. However, the positive predictive value of SIRS for predicting bacteraemia was only 7%. Patients who did not fulfil SIRS criteria when blood cultures were taken were at low risk of bacteraemia and comprised 45% (121/270) of the study population. Three patients in this low-risk group had bacteraemia. Mortality in bacteraemic patients with severe sepsis or septic shock who were initially treated with ineffective antibiotics for up to 48 h was 80%, compared to 42% in those always treated appropriately.
Introduction
In general, patients presenting with sepsis are not difficult to recognize. However, the use of objective criteria to diagnose sepsis enables patients to be placed into defined epidemiological groups where prognosis can be predicted and response to treatment monitored. Standard definitions of sepsis 1 have been widely adopted for the investigation of innovative therapies for the treatment of sepsis, and recently these criteria have been used to study the epidemiology of sepsis. 2 The central concept to which these definitions relate is that of the systemic inflammatory response syndrome (SIRS). We have used criteria defining SIRS to study prospectively the epidemiology of sepsis in general medical patients who had blood taken for culture, and to determine the value of SIRS in predicting bacteraemia.
Methods

Eligible patients
Adults admitted to general medical wards of Southampton General Hospital between September and December 1993 who had blood cultures drawn. Patients known to be neutropenic were excluded.
Blood culture episodes
Definitions were as described by Bates etal. 3 Briefly, a blood culture episode was defined as a 48 h period starting when a blood culture was taken. Further blood cultures taken on the same patient after 48 h were considered to be a new episode. Episodes were excluded if the blood culture was drawn as a followup to a previous positive blood culture. A blood culture set was defined as any one blood drawing, regardless of the number of bottles filled. Blood cultures were processed for 6 days using a BacT/Alert continuous monitoring system (Organon Teknika).
Isolates were identified and antibiotic sensitivity tests performed using standard techniques.
Data collection
Patient charts were reviewed within 24 h of taking blood cultures and in all cases before the results of culture were known. Each blood culture episode was scored according to criteria defining SIRS (Table 1) . 1 Physical examination data were matched with the time of drawing blood. Haematological and biochemical results were collected after 2 to 4 days. Focal infection was defined: for urinary tract infection, >10 WBC/ml and >10 5 organisms/ml; for lower respiratory tract infection, presence of new consolidation on chest X-ray or isolation of a recognized pathogen in heavy growth; for other sites, culture of a pathogen from a normally sterile site, or radiological evidence of a collection. Infections such as cellulitis were defined clinically, when cultures were not diagnostic. Mortality was determined at 28 days.
Clinically important positive blood cultures
Positive blood culture results were discussed with the referring team by microbiology medical staff and classified as clinically important or contaminated on the basis of clinical consideration and laboratory criteria, including organism type, number of bottles positive and time to detection. Of 26 positive blood Adapted from reference 1.
culture episodes from the original study, 11 were classed as clinically important. These were subsequently combined with a further 53 clinically important positive blood culture episodes from similar adult patients occurring between July and August 1994. Data on these episodes were collected as before.
tables were used,
Statistical analysis
Fisher's exact test and 2 x 2 performed using Epi-info 6.
Results
Blood culture episodes and the systemic inflammatory response syndrome
Epidemiological data for 270 unselected blood culture episodes are shown in Tables 2 and 3 . Of these episodes, 149 (55%) fulfilled SIRS criteria. Antibiotics were started in 117 of these 149 episodes (79%).
Severe sepsis occurred in 13 (5%) blood culture episodes and septic shock in 9 (3%) episodes. Blood culture episodes that met SIRS criteria were more likely to have a source of infection confirmed than blood culture episodes that did not meet SIRS criteria (p = 0.01, odds ratio 2.1, 95% Cl 1.1-4.0: Figure 1 ). In the non-SIRS group, 17% (21/121) had evidence of organ hypoperfusion, predominantly presenting with acute confusion, despite having no evidence of an acute host response. Mortality in these patients was 29% (6/21) compared with 9% (9/100) in those where features of organ hypoperfusion were not noted (p = 0.02, OR 4.0, 95% Cl 1.1-15.0). All estimates are of crude mortality and not mortality directly attributable to SIRS.
Bacteraemia and the systemic inflammatory response syndrome
Clinically important bacteraemia was detected in 11/270 (4%) unselected blood culture episodes. All occurred in patients who met criteria defining SIRS at the time blood was drawn, representing 7% of (13) 20 (17) 10 (8) 8 (7) 8 (7) 6 (5) 2 ( (23) 23 (15) 10 (7) 9 (6) 8 (5) 5 (3) 4 (3) 3 (2) 4 (3) 149
Clinically important positive blood culture episodes
64 "Some patients appear more than once.
this group. However, 138/149 (93%) blood cultures taken from patients manifesting SIRS were negative (Table 5 ). In a subsequent study of 64 clinically important positive blood cultures (Tables 2 and 3 ), 9 5 % (61/64) occurred in patients w h o met SIRS criteria when the blood cultures were drawn (Table 6 ). Blood culture isolates were typical of large series 4 ' 5 ( Table 7) .
Inappropriate empirical antibiotic therapy was given in 27/64 episodes (42%) of clinically important bacteraemia. In 10 episodes (16%) no antibiotics were prescribed until the blood culture was noted to be positive. In 17 (27%) episodes, the organism isolated from blood was resistant in vitro to the empirical antibiotics prescribed. Therapy was modified by medical microbiology staff in 44 (69%) episodes following detection of a positive blood culture, thus in 60 (94%) episodes, appropriate antibiotic therapy was instituted within 48 h of the blood culture being taken. Seven patients died prior 13 (39) 17 (29) 14 (24) 44 (30) 11 (20) 9 (14) 20 (17) 64 (24) Clinical infection (%) 19 (58) 34 (59) 20 (34) 73 (49) 24 (44) 23 (35) 47 (39) 120 (44) No infection (%) 1 (3) 7 (12) 24 (41) 32 (21) 20 (36) 34 (52) 54 (45) 86 (32) Confirmed infections were confirmed by microbiology or radiology. In 'clinical' infections, antibiotic therapy was started at time of taking blood cultures, but infection was not subsequently confirmed. 'No infection' indicates no antibiotic therapy and no subsequent evidence of infection.
•Individual criteria: T, temperature; H, heart rate; R, respiratory rate; L, leucocyte count. Table 1 for definitions).
to positive blood culture, of whom four had been prescribed inappropriate therapy.
Death occurred in 38% (24/64) of episodes of clinically important bacteraemia. Of those who died, 10 (42%) were given inappropriate empirical antibiotic therapy for up to 48 h. Overall, those treated inappropriately were no more likely to die than those treated appropriately (p=0.95, OR 1.0, 95% Cl Fisher's exact test, p = 0.001; positive predictive value of SIRS predicting bacteraemia, 7%. Table 6 Classification of 64 clinically important positive blood culture episodes according to SIRS criteria 2 In 59% of episodes of suspected sepsis no pathogen was isolated. In Southampton, no pathogen was isolated in 62% of episodes of suspected sepsis. Mortality was similar whether or not a pathogen was isolated. Severe sepsis accounted for 5% of blood culture episodes in Southampton, compared to 27% of patients in Iowa. Other than recording blood pressure, evidence that could be used to determine the presence of severe sepsis, such as acute confusion, metabolic acidosis or oliguria was noted in only 39/149 (26%) episodes of SIRS, suggesting that either the severity of illness was not fully appreciated in many of the episodes in this study, or the recording of important data in patient notes was poor. The incidence of septic shock was equivalent in both studies, at 3% in Southampton and 5% in Iowa.
Crude mortality within 28 days was 23% for patients who manifested SIRS and 12% in those who did not meet SIRS criteria. A sequential increase in mortality was observed as more SIRS criteria were fulfilled, ranging from 14% in those who met two SIRS criteria to 36% in those who met four criteria. These figures compare with the study of SIRS in Iowa, 2 where mortality was estimated at 7%, 10%
and 17% in patients fulfilling two, three and four SIRS criteria, respectively. Mortality from severe sepsis and septic shock was 38% and 56%, respectively in this study, compared with 20% and 40% in Iowa. The sequential rise in mortality with increasing numbers of SIRS criteria manifested was common to both studies despite differences in case mix. This suggests that SIRS definitions are of generalized use in predicting outcome from infection. Mortality in those with evidence of organ hypoperfusion, but not manifesting SIRS criteria was 29%. Current sepsis definitions 1 would exclude these patients from the severe sepsis category despite a similar mortality rate. A higher mortality was seen in all groups in comparison to Iowa, including the non-SIRS group (12% vs. 3%). Evidence of severe sepsis was infrequently recorded as sought in this study and may account for some of the excess mortality seen in SIRS groups only, but not for that in the non-SIRS, severe sepsis and septic shock groups. A higher mortality is consistently seen in the placebo arm of multicentre studies of immunomodulatory therapy for sepsis when comparing the UK with the USA.
In this study, 95% of clinically important bacteraemia occurred in patients who met SIRS criteria when the blood cultures were taken. Fulfilment of SIRS criteria is a sensitive predictor of bacteraemia in general medical patients. However, most patients manifesting SIRS will not be bacteraemic, and the positive predictive value of SIRS for predicting bacteraemia was only 7%. Non-fulfilment of SIRS criteria identified a group at low risk of bacteraemia comprising 45% of the study population. In Boston USA, patients with contaminated blood cultures remained in hospital for a median stay of 4.5 days longer than patients with negative blood cultures, at a cost of $4500 per patient. 7 Identifying a low-risk group could enable significant savings to be made by avoiding misinterpretation of contaminated blood cultures. It is of interest that in this group 5% (3/64) of episodes of clinically important bacteraemia occurred. Two of the cases had streptococcal endocarditis, and the third was of central venous catheterrelated bacteraemia due to Staphylococcus epidermidis. The systemic inflammatory response syndrome identifies an acute host response to noxious stimuli, and inevitably it will be less sensitive in detecting sub-acute and chronic disease processes, including those associated with bacteraemia. Microbiological diagnosis of infections which do not result in sepsis require culture of a specimen from the relevant site of infection. In the case of suspected endocarditis or intravenous-catheter-related infection, the correct specimen is blood. In patients presenting with localized infection, bacteraemia is unlikely unless SIRS criteria are met. A small group of patients will fail to mount a significant host response to serious acute infection and they too may be missed using SIRS to predict bacteraemia. This group has a poor prognosis 4 
even with optimal management. Other features found in severe sepsis, including unexplained acute confusion, metabolic acidosis, hypotension or acute renal failure are often present in these cases 8 and their presence represents another indication for performing blood cultures in patients who do not fulfil basic SIRS criteria. Furthermore, certain patients such as those on /?-blockers may not be suitable for assessment using SIRS criteria because they have a limited ability to develop a tachycardia in response to infection. Beta-blockers were contra-indicated in a high proportion of patients enrolled in the study.
Other models to predict bacteraemia have been put forward. Assessing unselected blood culture episodes, Bates and colleagues 3 found that scoring the presence of fever, serious underlying disease, rigors, intravenous drug abuse, an acute abdomen on examination, or major co-morbidity, could identify groups at high and low risk of bacteraemia. This work has recently been validated elsewhere. 10 Whilst this model can predict bacteraemia, these criteria are of little positive value in identifying those patients who are severely ill with focal nonbacteraemic sepsis, where the presence or absence of bacteraemia is irrelevant to the overall management of the patient. Fever of > 38 °C, or hypothermia of < 3 6°C has been recommended as a standard for performing blood cultures. 11 ' 12 In this study, 57%
of blood culture episodes and 23% of patients with clinically important bacteraemia would have been missed using these criteria. Others estimate that 13-24% of clinically important bacteraemia occurs in afebrile individuals. 13 ' 14 Of patients admitted to the ICU with a primary diagnosis of sepsis, 15 54%
had a temperature of 35.5-38.0 °C.
The overall mortality from bacteraemia was 38%, which is consistent with previous estimates of 20-50%. 16 Inappropriate empirical antibiotic therapy was prescribed for 42% of episodes, however amendments made by a medical microbiologist on detection of a positive blood culture resulted in 94% of patients being on appropriate therapy within 48 h. In the remaining 6% of episodes the patient was dead before the result was known. This compares favourably with current American quality standards. 17 ' 18 Estimates of the scale of inappropriate empirical antibiotic therapy range from 28 to 64% of all cases of significant bacteraemia. 19 24 have been shown to reduce inappropriate prescribing and to reduce costs. Patients with severe sepsis or septic shock who were treated with inappropriate antibiotic therapy had a crude mortality within 28 days of 80% compared to 42% in those treated appropriately. This was not significant statistically (p = 0.08), however, given the small numbers involved, it represents a trend that requires further investigation. Such data suggest that patients who present with severe sepsis or septic shock should be discussed on admission with a medical microbiologist, or infectious disease physician, to enable optimal antibiotic therapy to be prescribed.
Limitations of the study
No attempt was made to measure the volume of blood collected for each blood culture set. Culture of inadequate volumes of blood may have biased the distribution of positive blood cultures across the SIRS groupings created. Furthermore, there is no independent gold standard by which to assess bacteraemia. Discussion with the clinical team may have resulted in misclassification of some blood culture results.
Patients entered into the trial had already had blood cultures taken. No data exist on the risk of bacteraemia in patients fulfilling SIRS criteria but not having blood cultures drawn. Thus, the main outcome of this study is negative, giving more indication of when not to take blood cultures than when to take them. Blood culture episodes were entered into the trial prospectively, but information regarding each episode was collected after the blood cultures were taken and thus, was retrospective in nature. Considerable effort was made to obtain chart readings recorded at the time blood cultures were drawn, but this is a possible source of bias. Data for unselected blood culture episodes were collected before the results of culture were known. Subsequent study of known positive blood cultures could not be similarly blinded, however, the reviewer knew only that the blood culture was positive.
Conclusions
Knowledge of SIRS provides a useful guide to clinical decision-making in patients who present with suspected sepsis. For patients who fulfil SIRS criteria and are suspected of having sepsis, evidence of organ hypoperfusion should be sought. If such evidence is found, appropriate empirical antimicrobial therapy should be discussed with a medical microbiologist or infectious disease physician and adequate supportive treatment ensured. Patients who do not fulfil SIRS criteria are unlikely to be bacteraemic, unless a cardiovascular focus of infection is suspected, they have evidence of organ hypoperfusion or are on beta-blockers. Assessment of SIRS status at the time of taking blood may assist in deciding whether a positive blood culture is significant or a contaminant.
